why choose us

First received: January 30, 2025

Clinical Trial: Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: mCRPC

Study Type: OBSERVATIONAL


Official Title: Swiss Cancer Registry on Safety and Efficacy of 177Lu-ITG-PSMA-1 Radionuclide Therapy in Prostate Cancer Patients

Brief Summary: The goal of this observational study (multicenter, national registry-based) is to evaluate the performance of 177Lu-ITG-PSMA-1 (177Lu-PSMA-I&T) as therapy in patients with metastatic castration resistent prostate cancer (mCRPC).The main questions are whether the 177Lu-PSMA-I&T is safe and if it works well to treat patients with progressive mCRPC.The data and information in the study are collected under standard medical therapy and follow-up, so called real-world conditions.Participants will:undergo regular…

Read more